Joseph Park, PharmD, MBA, is an accomplished healthcare executive with extensive experience in the life sciences and startup environments, leading cross-functional teams in corporate development, business operations, and clinical strategy. He has held key roles at companies like Modifi Biosciences (acquired by Merck) , Prelude Therapeutics , and Audentes Therapeutics (acquired by Astellas Pharma), contributing to significant acquisitions and strategic initiatives. As an advisor in life sciences, he is known for enabling strategic alignment, investor engagement, and building scalable systems that drive mission-focused outcomes in high-growth organizations and startups.